Home/Pelage Pharmaceuticals/Christina Weng, MD
CW

Christina Weng, MD

Chief Medical Officer

Pelage Pharmaceuticals

Pelage Pharmaceuticals Pipeline

DrugIndicationPhase
PP405Androgenetic Alopecia (Pattern Hair Loss)Phase 2a